OncDRS: An integrative clinical and genomic data platform for enabling translational research and precision medicine
نویسندگان
چکیده
We live in the genomic era of medicine, where a patient's genomic/molecular data is becoming increasingly important for disease diagnosis, identification of targeted therapy, and risk assessment for adverse reactions. However, decoding the genomic test results and integrating it with clinical data for retrospective studies and cohort identification for prospective clinical trials is still a challenging task. In order to overcome these barriers, we developed an overarching enterprise informatics framework for translational research and personalized medicine called Synergistic Patient and Research Knowledge Systems (SPARKS) and a suite of tools called Oncology Data Retrieval Systems (OncDRS). OncDRS enables seamless data integration, secure and self-navigated query and extraction of clinical and genomic data from heterogeneous sources. Within a year of release, the system has facilitated more than 1500 research queries and has delivered data for more than 50 research studies.
منابع مشابه
Combining clinical and genomics queries using i2b2 – Three methods
We are fortunate to be living in an era of twin biomedical data surges: a burgeoning representation of human phenotypes in the medical records of our healthcare systems, and high-throughput sequencing making rapid technological advances. The difficulty representing genomic data and its annotations has almost by itself led to the recognition of a biomedical "Big Data" challenge, and the complexi...
متن کاملRembrandt: helping personalized medicine become a reality through integrative translational research.
Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be ...
متن کاملAn Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Cancer is a heterogeneous disease caused by diverse genomic alterations in oncogenes and tumor suppressor genes. Despite recent advances in high-throughput sequencing technologies and development of targeted therapies, novel cancer drug development is limited due to the high attrition rate from clinical studies. Patient-derived xenografts (PDX), which are established by the transfer of patient ...
متن کاملA fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.
Identification of clinically relevant tumor subtypes and omics signatures is an important task in cancer translational research for precision medicine. Large-scale genomic profiling studies such as The Cancer Genome Atlas (TCGA) Research Network have generated vast amounts of genomic, transcriptomic, epigenomic, and proteomic data. While these studies have provided great resources for researche...
متن کاملGenome Sequencing Practices and the Future of Clinical Research
Genome sequencing is one of the latest technologies to be introduced for use in clinical trials. It is often used in the practice of genomic medicine, with the objective of processing information about genes and markers to treat disease. Specifically, genomic medicine uses DNA and RNA platform sequencing technologies to analyze the human genome to detect diseases caused by gene mutations. In 20...
متن کامل